Double egret pharmaceutical heavy product Fu Ji complex gel is expected to be approved for production in about a month.
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In July 2nd, the website of the State Food and Drug Administration (CFDA) showed that the state of "Fu Ji complex gel" (the full name: recombinant human basic fibroblast growth factor gel) was changed to "approval", and it is expected to get production approval in about a month Fu Ji Fu is a listed product of Shuang Lu pharmaceutical, which is mainly used to promote wound healing The gel used by the company is a new dosage form for Fu Ji Fu Liang Shujie, the company's secretaries, gave high hopes to the variety, saying that Fu Ji Fu is a relatively promising variety of the company With the listing of gel formulations, it is expected to become a potential variety of billions of dollars in the future Liang Shujie has said that it is expected that the new dosage form will get the production approval 2 or 3 months later or by the end of this year The product is a "more promising variety than coenzyme" It has good clinical effects in gynecology and other fields Now it has chosen a strong distributor The key sales provinces will be Beijing and Shandong In 2005, the double Heron pharmaceutical filed the clinical approval of the Fu Ji complex gel, and ended the on-site inspection at the end of 2012 Since the inspection report was transferred to the drug review center, the declared status of the product had been suspended since June 19, 2013, and the suspension lasted for 10 months.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
